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Summary
The role of long noncoding RNA (lncRNA) in adult hearts is unknown; also unclear is how 
lncRNA modulates nucleosome remodeling. An estimated 70% of mouse genes undergo antisense 
transcription1, including myosin heavy chain 7 (Myh7) that encodes molecular motor proteins for 
heart contraction2. Here, we identify a cluster of lncRNA transcripts from Myh7 loci and show a 
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new lncRNA–chromatin mechanism for heart failure. In mice, these transcripts, which we named 
Myosin Heavy Chain Associated RNA Transcripts (MyHEART or Mhrt), are cardiac-specific and 
abundant in adult hearts. Pathological stress activates the Brg1-Hdac-Parp chromatin repressor 
complex3 to inhibit Mhrt transcription in the heart. Such stress-induced Mhrt repression is 
essential for cardiomyopathy to develop: restoring Mhrt to the pre-stress level protects the heart 
from hypertrophy and failure. Mhrt antagonizes the function of Brg1, a chromatin-remodeling 
factor that is activated by stress to trigger aberrant gene expression and cardiac myopathy3. Mhrt 
prevents Brg1 from recognizing its genomic DNA targets, thus inhibiting chromatin targeting and 
gene regulation by Brg1. Mhrt binds to the helicase domain of Brg1, and this domain is crucial for 
tethering Brg1 to chromatinized DNA targets. Brg1 helicase has dual nucleic acid-binding 
specificities: it is capable of binding lncRNA (Mhrt) and chromatinized—but not naked—DNA. 
This dual-binding feature of helicase enables a competitive inhibition mechanism by which Mhrt 
sequesters Brg1 from its genomic DNA targets to prevent chromatin remodeling. A Mhrt-Brg1 
feedback circuit is thus crucial for heart function. Human MHRT also originates from MYH7 loci 
and is repressed in various types of myopathic hearts, suggesting a conserved lncRNA mechanism 
in human cardiomyopathy. Our studies identify the first cardioprotective lncRNA, define a new 
targeting mechanism for ATP-dependent chromatin-remodeling factors, and establish a new 
paradigm for lncRNA–chromatin interaction.
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By 5′- and 3′-rapid amplification of cDNA ends, we discovered an alternative splicing of 
Myh7 anti-sense transcription into a cluster of RNAs of 709 to 1147 nucleotides (Mhrts), 
containing partial sequences of Myh7 introns and exons (Fig. 1a, Supplementary 
information). Mhrts were cardiac-specific (Fig. 1b), present at low levels in fetal hearts, with 
increasing abundance as the hearts matured and Myh6/Myh7 increased (Fig. 1c). RNA in situ 
analysis showed that Mhrts resided in the myocardium but not endocardium or epicardium 
(Fig. 1d, Extended Data Fig. 1a). Quantitation of nuclear/cytoplasmic RNA in heart extracts 
revealed that Mhrts were primarily nuclear RNAs (Fig. 1e). Coding substitution 
frequencies4,5 of Mhrts predicted a negative/low protein-coding potential, in vitro translation 
of Mhrts yielded no proteins, and ribosome profiling6 revealed no/minimal ribosomes on 
Mhrt (Fig. 1f, Extended Data Fig. 1b–f, Supplementary text). Consequently, Mhrts are non-
coding RNAs in cardiomyocyte nuclei.
Mhrts were down-regulated by 46–68% in hearts pressure-overloaded by transaortic 
constriction (TAC)3, beginning by 2 days and lasting for ≥42 days after TAC (Fig. 2a). Such 
Mhrt reduction coincided with TAC-induced Myh6/7 isoform switch characteristic of 
cardiomyopathy7-9 (Extended Data Fig. 2a). To define Mhrt function, we focused on 
Mhrt779, the most abundant Mhrt species with 779 nucleotides (Fig. 2b and 2c, Extended 
Data Fig. 2b–e). We generated a transgenic mouse line to restore Mhrt779 level in stressed 
hearts. This transgenic line, driven by tetracycline response element (Tre-Mhrt779), was 
crossed to a cardiac-specific driver line (Tnnt2-rtTA)3 that employs troponin promoter 
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(Tnnt2) to direct expression of reverse tetracycline-dependent transactivator (rtTA). The 
resulting Tnnt2-rtTA;Tre-Mhrt779 line (abbreviated as Tg779) enabled the use of 
doxycycline to induce Mhrt779 expression in cardiomyocytes. Within 7–14 days of 
doxycycline (dox) treatment, Mhrt779 increased by ~1.5-fold in left ventricles of Tg779 
mice; this offset Mhrt779 suppression in TAC-stressed hearts to maintain Mhrt779 at pre-
stress level (Fig. 2d). Six weeks after TAC, dox-treated control mice (Tre-Mhrt779, Tnnt2-
rtTA, or wild-type) developed severe cardiac hypertrophy and fibrosis with left ventricular 
(LV) dilatation and reduced fractional shortening (FS). Conversely, dox-treated Tg779 
hearts—with Mhrt779 maintained at pre-stress level—developed much less pathology, with 
45.7% reduction of ventricle/body-weight ratio (Fig. 2e), 61.3% reduction of cardiomyocyte 
size (Fig. 2f, Extended Data Fig. 3a), minimal/absent cardiac fibrosis (Fig. 2g), 45.5% 
improvement of FS (Fig. 2h, Extended Data Fig. 3b), normalized LV size (Fig. 2i), and 
reduced pathological changes of Anf, Bnp, Serca2, Tgfb1, and Opn expression10-13 
(Extended Data Fig. 3c and 6e). To further test cardioprotective effects of Mhrt, we induced 
Mhrt779 after 1–2 weeks of TAC when hypertrophy had begun. This approach reduced 
hypertrophy by 23% and improved FS by 33% in 8 weeks after TAC (Extended Data Fig. 
3d–f). The efficacy of late Mhrt779 introduction suggests that a sustained repression of Mhrt 
in stressed hearts is essential for continued decline of cardiac function.
To study Mhrt regulation, we examined the 5′ upstream region of Mhrts (−2329 to +143) 
(Extended Data Fig. 4a) for signatures of lncRNA promoter: RNA Polymerase II (PolII), 
histone 3 tri-methylated lysine 4 (H3K4me3), and histone 3 tri-methylated lysine 36 
(H3K36me3)4,14,15. By chromatin immunoprecipitation (ChIP) of left ventricles, we found 
that this putative promoter contained four evolutionarily conserved elements (a1 to a4)3 that 
were enriched with PolII (a1 to a4), H3K4me3 (a1 and a4), and H3K36me314,16-18 (a1 and 
a3/a4) (Extended Data Fig. 4a–d). Conversely, no PolII, H3K4me3, or H3K36me3 
enrichment was found in control Shh and Vegfa promoters or in thymus and lungs that did 
not express Mhrts (Extended Data Fig. 4b–d). These results reveal an active, cardiac-specific 
lncRNA promoter controlling Mhrt expression.
We then asked how Mhrt was repressed in stressed hearts. We postulated that cardiac stress 
activated Brg1 to occupy a1–a4 promoter to repress Myh63 and Mhrt in opposite 
transcription directions (Extended Data Fig. 4a). Indeed, Mhrt repression required Brg1: 
TAC suppressed Mhrts in control but not Brg1-null hearts (Tnnt2-rtTA;Tre-Cre;Brg1f/f)3 
(Extended Data Fig. 4e). To test Brg1 activity on Mhrt promoter, we cloned the a1-a4 
promoter in Mhrt transcription direction (−2329 to +143) into an episomal luciferase 
reporter pRep4 that allows promoter chromatinization19. Brg1 was then transfected into 
Brg1-deficient SW13 cells20 to reconstitute Brg1/BAF complex for reporter assays. Brg1 
transfection caused ~50% reduction of Mhrt promoter activity (p<0.0001), and such Mhrt 
repression was virtually abolished by Hdac inhibition with trichostatin-A or Parp inhibition 
with PJ-3421 (Extended Data Fig. 4f), indicating a cooperative repressor function between 
Brg1, Hdac, and Parp. ChIP verified that Mhrt promoter (a1-a4) was occupied by Brg1, 
Hdac2/9 and Parp1 in stressed hearts3 and in pRep4 reporter episome (Extended Data Fig. 
4g). These findings indicate that Mhrt is repressed by stress-induced Brg1–Hdac-Parp 
complex3 through the a1–a4 promoter.
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Because Myh6 and Mhrt were both regulated by the a1–a4 promoter, we hypothesized that 
a1–a4 contained two elements to regulate Myh6 and Mhrt—with a1 element controlling 
Myh6 and a3/4 Mhrt (Extended Data Fig. 4a). On a1 and a3/4 (but not a2), we found 
cardiac-specific enrichment of Brg13, H3K4me3 and H3K36me3 (Extended Data Fig. 4c-d), 
and DNaseI genomic footprints (Fig. 3a)22. To test a3/4 for Mhrt regulation, we conducted 
deletional analysis of a1-a4 promoter in Mhrt transcription direction. In reporter assays, a3/4 
was necessary and sufficient for Mhrt promoter activity and for Brg1-dependent Mhrt 
repression, whereas a1 was not essential for such controls (Extended Data Fig. 4h). 
Conversely, a1 is necessary and sufficient for Brg1 to repress Myh6 promoter3, but a3/4 is 
not required3. Therefore, a1 and a3/4 are two functionally distinct elements for Brg1 to 
separately control Myh6 and Mhrt.
In stressed hearts Brg1 represses Myh6 and activates Myh73, causing a pathological switch 
of Myh6/7 expression, characteristic of cardiomyopathy23. Such stress/Brg1-dependent Myh 
switch was largely eliminated by Mhrt779 (Fig. 3b), and the inhibition of Myh switch by 
Mhrt did not involve RNA-RNA sequence interference between Mhrt and Myh (Extended 
Data Fig. 5a-j, Supplementary text). Instead, it required physical interaction between Mhrt 
and Brg1. RNA immunoprecipitation of TAC-stressed adult hearts or Brg1-expressing 
neonatal hearts showed that Brg1 co-immunoprecipitated with Mhrt779 but not control 
RNAs, and Mhrt779 complexed with Brg1 but not polycomb Ezh2 or Suz2 (Fig. 3c, 
Extended Data Fig. 6a and 6b). The Brg1-Mhrt complex was minimal in unstressed adult 
hearts with low Brg13 or in stressed Brg1-null hearts (Tnnt-rtTA;Tre-Cre;Brg1f/f)3 (Fig. 3c, 
Supplementary text). These results suggest that Mhrt binds to Brg1 to influence its gene 
regulation.
We then tested how Mhrt regulated Brg1 activity on its in vivo target genes, including 
Myh63, Myh73, and Opn (Osteopontin, critical for cardiac fibrosis12)(Extended Data Fig. 
6c–e, Supplementary text). In dox-treated, TAC-stressed Tg799 hearts, Mhrt779—without 
affecting Brg1 mRNA/protein level (Extended Data Fig. 7a-f)—reduced Brg1 occupancy on 
Myh6, Myh7 and Opn promoters by 60–90% (Fig. 3d), causing a 56–76% loss of Brg1-
controlled Myh switch and Opn activation (Fig. 3b, Extended Data Fig. 6e and 7g). We then 
used primary rat ventricular cardiomyocytes to conduct reporter assays. In these cells, as 
observed in vivo, Brg1 repressed Myh6 and activated Myh7 and Opn promoters; Mhrt779 
reduced Brg1 activity on these promoters by 54–80% (Fig. 3e). Accordingly, Mhrt prevents 
Brg1 from binding to its genomic targets to control gene expression.
How Brg1 or ATP-dependent chromatin remodelers recognize their target promoters is an 
important but not fully understood issue in chromatin biology. Biochemically, recombinant 
Brg1 proteins and in vitro transcribed Mhrt779 could directly co-immunoprecipitate without 
involving other factors (Fig. 3f). Electrical mobility shift assay (EMSA) showed that Brg1 
shifted biotin-labeled Mhrt779 to form a low mobility protein–RNA complex that was 
competitively disrupted by unlabeled Mhrt779 (Fig. 3f). Brg1, which belongs to SWI/SNF 
family of chromatin-remodeling factors, contains a helicase/ATPase core that is split by an 
insertion into two RecA-like domains: DExx-c (DEAD-like helicase superfamily c-terminal 
domain, D1) and HELIC-c (helicase superfamily c-terminal domain, D2)24,25 with signature 
motifs of DEAD-box, superfamily 2 RNA helicase25,26 (Fig. 3g, Extended Data Fig. 8). 
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SWI/SNF proteinş although conserved with RNA helicases, were observed to bind DNA27 
and mediate DNA structural changes and repair19. The binding properties of Brg1 remained 
undefined. To test if Mhrt could bind to Brg1 helicase, we generated MBP-tagged 
recombinant proteins that contained Brg1 DExx-c domain (MBP-D1, amino acid 774–913), 
HELIC-c domain with C-terminus extension (MBP-D2, 1086–1310), or entire helicase 
(MBP-D1D2, 774–1310)(Extended Data Fig. 9a). D1D2 showed the highest Mhrt binding 
affinity (Kd = 0.76 μM); D1 moderate (Kd = 1.8 μM); D2 modest (Kd > 150 μM); MBP no 
binding (Fig. 3h and 3i). Therefore, Brg1 helicase binds Mhrt with high affinity.
Contrary to its potent RNA binding, Brg1 helicase had no detectable binding to the naked 
DNA of Myh6 promoter (596bps, −426 to +170, critical for Brg1’s control of Myh63) 
(Extended Data Fig. 9b). To test if Brg1 helicase could bind chromatinized DNA, we 
generated nucleosomal DNA in vitro by assembling histone octamers (histone 2A, 2B, 3, 
and 4)28 on Myh6 promoter DNA, as well as on control Neo and 5SrDNA. We achieved 50–
65% efficiency of nucleosome assembly, comparable among Myh6, Neo, and 5SrDNA (Fig. 
4a). Because the large nucleosome size precluded a clear EMSA resolution, we used 
amylose to pull down MBP-tagged D1D2 proteins. We found that D1D2 pulled down 
nucleosomal Myh6 promoter DNA but not the naked one (Fig. 4b). The pull-down efficiency 
of nucleosomal Myh6 was ~3–6-fold that of Neo or 5SrDNA (Fig. 4c), and Mhrt779 was 
capable of disrupting D1D2-Myh6 pull-down (Fig. 4d). Although D1D2 bound to histone 3 
(Fig. 4e), histone binding was insufficient to anchor D1D2 to nucleosomal DNA, as D1D2 
bound poorly to nucleosomal Neo and 5SrDNA that also contained histones (Fig. 4c). 
Therefore, chromatinized DNA targets are biochemically recognized by Brg1 helicase, and 
this process is inhibited by Mhrt.
To test the ability of Brg1 to distinguish chromatinized from naked DNA promoters in cells, 
we cloned Myh6 promoter into the luciferase reporter plasmid pREP4 (allowing promoter 
chromatinization19) and pGL3 (containing naked, non-chromatinized promoter). In rat 
ventricular cardiomyocytes and SW13 cells, ChIP and luciferase analyses showed that Brg1 
bound and repressed chromatinized but not naked Myh6 promoter (Fig. 4f and 4g, Extended 
Data Fig. 9c and 9d). However, without D1/D2 domain or in the presence of Mhrt, Brg1 was 
unable to bind or repress chromatinized Myh6 promoter (Fig. 4h–j, Extended Data Fig. 9e), 
indicating the necessity of D1D2 for the interaction between Brg1, chromatin, and Mhrt. 
Consistently, all our genetic, biochemical, and cellular studies show that Brg1 requires the 
helicase domain to bind to chromatinized DNA targets, and Mhrt seizes the helicase to 
disrupt Brg1–chromatin binding.
We then asked how Brg1 surpassed its basal suppression by Mhrt to control Myh, Mhrt, 
Opn, or other genes to trigger cardiomyopathy (Supplementary text). Amylose pull-down 
experiments showed that Brg1 dose-dependently escaped from Mhrt inhibition to occupy 
Mhrt promoter (Extended Data Fig. 10). Brg1 protein, which increases under stress 
conditions3, could therefore outrun Mhrt and gain control over Mhrt promoter to repress 
Mhrt expression and tip the balance toward Brg1. Contrary to the endogenous Mhrt that was 
repressible by Brg1, the Mhrt transgene (Tg779)—driven by Tnnt2/Tre promoters—was not 
subject to Brg1’s repression and thus able to keep Mhrt at pre-stress level to inhibit Brg1 
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and reduce hypertrophy. This further demonstrates the necessity of Mhrt repression for 
myopathy to develop.
Human MYH7 loci encoded RNA that resembled Mhrt in primary sequence and secondary 
structure predicted by minimal free energy29 (Fig. 4k, Extended Data Fig. 11a and 11b). The 
human MHRT was also repressed in stressed hearts, with 82.8%, 72.8%, and 65.9% 
reduction of MHRT in hypertrophic, ischemic or idiopathic cardiomyopathy tissues (Fig. 4l, 
Extended Data Fig. 11c). This suggests a conserved Mhrt mechanism of human 
cardiomyopathy.
Discussion
Mhrt is the first example of lncRNA that inhibits myopathy and chromatin remodelers. 
Reciprocal Mhrt-Brg1 inhibition constitutes a negative feedback circuit critical for 
maintaining cardiac function (Fig. 4m). The helicase core of Brg1, combined with histone-
binding domains of Brg1/BAF complex, adds a new layer of specificity control to 
Brg1/BAF targeting and chromatin remodeling (Fig. 4n). The Mhrt–helicase interaction also 
exemplifies a new mechanism by which lncRNA controls chromatin structure. To further 
elucidate chromatin regulation, it will be essential to define helicase domain function in all 
ATP-dependent chromatin-remodeling factors and to identify new members of lncRNA that 
act through this domain to control chromatin. The cardioprotective Mhrt may have 
translational value, given that RNA can be chemically modified and delivered as a 
therapeutic drug. This aspect of lncRNA–chromatin regulation may also inspire new 
therapies for human disease.
METHODS
Mice, animal sample size, and randomization
For the generation of Tg779 mice, Mhrt779 was cloned into pTRE2 backbone (Clonetech, 
CA). DNA fragment containing the Tre promoter, and Mhrt779 was injected into the 
pronucleus of fertilized oocytes (B6C3H/F1). Embryos were implanted into a 
pseudopregnant CD-1 mouse. Tre-Mhrt779 transgene was identified by PCR genotyping 
using primers (CGCCTGGAGACGCCATCCAC; TGTCTTCAAAGCTGACTCCCT). Tre-
Mhrt779 mice with ~3 copies of the transgene were backcrossed with Tnnt2-rtTA mice as 
described previously3,30 to generate Tnnt2-rtTA; Tre-Mhrt779 (Tg779) mice. The number of 
animals used (N) was denoted in each test in the figures, including technical replicates when 
applicable. We routinely used mouse littermates to control and perform our experiments. 
Each subgroup of experiments had N = 3 to 14 biological replicates, many of which had 
technical replicates of three. The assignment to each experimental subgroup was based on 
the genotypes. Littermate mice with the same genotypes regardless of gender were randomly 
selected from the cage and assigned to different control and experimental subgroups. Major 
procedures were blinded. The use of mice for studies was in compliance with the regulations 
of Indiana University, Stanford University, and National Institute of Health.
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RACE and cloning of full length of Mhrt transcripts
The 3′ and 5′ RACE were performed using the FirstChoice RLM-RACE Kit (Ambion) 
following the manufacture’s instruction. RNA was extracted from adult heart ventricles. 
Primers used for 3′ and 5′ RACE were designed based on the known sequence information: 
TCATTGGCACGGACAGCATC (First-round Mhrt 3′-prime specific) and 
GAGCATTTGGGGATGGTATAC (Second-round Mhrt 3′-prime specific); 
CAACACTTTTCATTTTCCTCTTT (First-round Mhrt 5′-prime specific) and 
TCTGCTTCATTGCCTCTGTTT (Second-round Mhrt 5′-prime specific). Once we reached 
the 5′- and 3′-cDNA ends, we used primers F1 (Fig. 1a, 
AAGAGCCCTACAGTCTGATGAACA) and R1 Fig. 1a, 
CCTTCACACAAACATTTTATTT) to amply the full-length Mhrt transcripts and cloned 
into pDrive TA cloning vector (Qiagen) and send for sequencing. Mhrts were also further 
cloned into shuttle vector pAdd231,32 for expression in cells.
Northern blot and in situ Hybridization
We obtained 5 μg of total RNA using Quick-RNA Mini Kit (Zymo Research). RNA blot 
was performed using NorthernMax Kit (Ambion) following the manufacturer’s protocol. 
Single stranded RNA probe was generated by in vitro transcription with MaxIscript SP6/T7 
kit (Ambion) with ATP [α-32P] (PerkinElmer) using full-length Mhrt779, Myh6 and Myh7 
as the template and followed by digestion with DNase I (Ambion). Hybridization was 
performed at 65°C. The blot was washed and imaged by Phosphor storage scanning by 
Typhoon 8600 Imager (GE Healthcare). In situ hybridization experiments were performed 
as previously described3,33.
RNA fractionation
To isolate cytosolic and nuclear RNAs from adult heart tissues, we used PARIS kit 
(Ambion) and followed the manufacturer’s instruction. 10 mg of tissues were homogenized 
in Cell Fractionation Buffer thoroughly before centrifuge for 5min at 500g. Supernatant was 
collected as cytosolic fraction, while nuclear pellet was washed and lysed by Cell Disruption 
Buffer. Such samples were further mixed with 2X Lysis/Binding Solution before extracting 
RNA using the manufacturer’s protocol.
Codon substitution frequency predication
To measure the coding potential of Mhrt, we used the previously described codon 
substitution frequencies (CSF) method4,5 to evaluate the evolutionary characteristics in their 
alignments with orthologous regions in 6 other sequenced mammalian genomes (Rat, 
Human, Hamster, Rhesus Monkey, Cat and Dog). CSF generates a likelihood score for a 
given sequence considering all codon substitutions observed within its alignment across 
multiple species, which was based on the relative frequency of similar substitutions occurred 
in known coding and noncoding regions. CSF compares two empirical codon models; one 
generated from alignments of known coding regions and the other according to noncoding 
regions, producing a likelihood ratio. The ratio reflects whether the protein-coding model 
better explains the alignment.
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Ribosome profiling and RNA deep sequencing
For ribosome profiling6, over-expression of predominant specie of Mhrt (Mhrt779) along 
with HOTAIR were achieved through co-transfecting pAdd2-779 and pAdd2-HOTAIR into 
SW13 cells. The cells were then lysed to extract ribosome-associated RNA fragments using 
ARTseq™ Ribosome Profiling Kit (Epicenter, Illumina). The RNA fragments were further 
converted into a DNA library through end repair, adaptor ligation, reverses transcription 
circularization, and PCR amplification. A conventional RNA-seq library was also prepared 
with total RNA extracted from those cells with miRNeasy Mini Kit (Qiagen #217004). The 
libraries were further processed according to MiSeq Sample Prep sheet, and MiSeq 50 cycle 
kit was used for sequencing. 1.25 picomoles PCR products were used for sequencing. 
600K~700K reads were properly paired and used for further analysis. The resulting reads 
were aligned to the human hg19 or mouse mm10 genome using Bowtie2 v2.0.0.634. Mapped 
reads were visualized on the UCSC browser as bigwig files generated using samtools 
v0.1.1835, bedtools v2.16.136, bedClip and bedGraphToBigWig. For quantification of 
FPKM values (fragments per kilobase of exon per million fragments mapped), cuffdiff as 
part of the tophat suite V2.0.8b37 was run on a merged bam file containing the human and 
the Mhrt reads using a custom gtf file comprising of the human hg19 iGenome and the Mhrt 
transcripts. To generate scatter plot of the genes, cuffdiff files were used for visualization 
with cummerbund v2.3.137. The data were uploaded to GEO (Gene Expression Omnibus) 
with accession number: GSE49716.
In vitro translation and biotin labeling
TNT Quick Coupled Transcription/Translation System (Promega) was used for in vitro 
translation. Briefly, 1 ug plasmids of control (Luciferase) and various Mhrt species inserted 
into pDrive vector were added to 40 ul rabbit reticulocyte lysates containing S35-methionine. 
After 1hr of incubation, the reactions were analyzed on 10–20% Tris-Tricine gel. The gel 
was dried and visualized by the Typhoon 8600 Imager (GE Healthcare). Biotin-NTP was 
added to in vitro translation reaction. Total RNAs were extracted and the biotin-labeled 
RNAs were detected subsequently by IRDye 680 Streptavidin (Li-COR, 926-68079) using 
Odyssey Infrared Imaging System.
Transaortic constriction (TAC)
The TAC surgery was performed as described3 on adult mice of 8–10 weeks of age and 
between 20 and 25 grams of weight. Mice were fed with doxycycline food pellets (6 mg 
doxycycline/kg of food, Bioserv, Frenchtown, NJ) 7–14 days prior to the TAC operation. 
Mice were anesthetized with isoflurane (2–3%, inhalation) in an induction chamber and then 
intubated with a 20-gauge intravenous catheter and ventilated with a mouse ventilator 
(Minivent, Harvard Apparatus, Inc). Anesthesia was maintained with inhaled isoflurane (1–
2%). A longitudinal 5-mm incision of the skin was made with scissors at midline of sternum. 
The chest cavity was opened by a small incision at the level of the second intercostal space 
2–3 mm from the left sternal border. While opening the chest wall, the chest retractor was 
gently inserted to spread the wound 4–5 mm in width. The transverse portion of the aorta 
was bluntly dissected with curved forceps. Then, 6–0 silk was brought underneath the 
transverse aorta between the left common carotid artery and the brachiocephalic trunk. One 
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27-gauge needle was placed directly above and parallel to the aorta. The loop was then tied 
around the aorta and needle, and secured with a second knot. The needle was immediately 
removed to create a lumen with a fixed stenotic diameter. The chest cavity was closed by 6–
0 silk suture. Sham-operated mice underwent similar surgical procedures, including isolation 
of the aorta, looping of aorta, but without tying of the suture. The pressure load caused by 
TAC was verified by the pressure gradient across the aortic constriction measured by 
echocardiography. Only mice with a pressure gradient >30 mmHg were analyzed for cardiac 
hypertrophy, echocardiography and other purposes.
Echocardiography
The echocardiographer was blinded to the genotypes and surgical procedure. Transthoracic 
ultrasonography with a GE Vivid 7 ultrasound platform (GE Health Care, Milwaukee, WI) 
and a 13 MHz transducer was used to measure aortic pressure gradient and left ventricular 
function. Echocardiography was performed on control and Tnnt2-rtTA;Tre-Mhrt779 (Tg779) 
mice designated time points after the TAC procedure. To minimize the confounding 
influence of different heart rates on aortic pressure gradient and left ventricular function, the 
flow of isoflurane (inhalational) was adjusted to anesthetize the mice while maintaining their 
heart rates at 450–550 beats per minute. The peak aortic pressure gradient was measured by 
continuous wave Doppler across the aortic constriction. The left ventricular function was 
assessed by the M-mode scanning of the left ventricular chamber, standardized by two-
dimensional, short-axis views of the left ventricle at the mid papillary muscle level. Left 
ventricular (LV) chamber size and wall thickness were measured in at least three beats from 
each projection and averaged. LV internal dimensions at diastole and systole (LVIDd and 
LVIDs, respectively) were measured. The fractional shortening (FS) of the left ventricle was 
defined as 100% × (1 - LVIDs/LVIDd), representing the relative change of left ventricular 
diameters during the cardiac cycle. The mean FS of the left ventricle was determined by the 
average of FS measurement of the left ventricular contraction over 5 beats. P-values were 
calculated by the Student-t test. Error bars indicate standard error of mean.
Histology, trichrome staining, and morphometric analysis of cardiomyocytes
Histology and trichrome staining were performed as described38,39. Trichrome Stain 
(Masson) kit (Sigma) was used and manufacture’s protocol was followed. For morphometric 
analysis of cardiomyocytes, paraffin sections of the heart were immunostained with a 
fluoresecin isothiocyanate-conjugated Wheat Germ Agglutinin (WGA) antibody (F49, 
Biomeda, Foster City, CA) that highlighted the cell membrane of cardiomyocytes. Cellular 
areas outlined by WGA were determined by the number of pixels enclosed using Image J 
software (NCBI). Approximately 250 cardiomyocytes of the papillary muscle at the mid left 
ventricular cavity were measured to determine the size distribution. P-values were calculated 
by the Student-t test. Error bars indicate standard error of mean.
Reverse transcription–quantitative PCR analysis (RT–qPCR) and strand specific reverse 
transcription PCR analysis
RT–qPCR analyses were performed as described3,38. The following primer sequences (listed 
below) were used. RT-qPCR reactions were performed using SYBR green master mix 
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(BioRad) with an Eppendorf realplex, and the primer sets were tested to be quantitative. 
Threshold cycles and melting curve measurements were performed with software. P-values 
were calculated by the Student-t test. Error bars indicate standard error of mean. To conduct 
strand specific RT PCR analysis, human total RNA and Superscript III First-Strand 
Synthesis System (Invitrogen) was used. Primers R1 (Fig. 4k, 
CTACAGAATGAGATCGAGGACT) and R2 (Fig. 4k, GGGGCTGAAGAGTGAGCCTT) 
were designed based on known sequence and used for individual RT respectively. To detect 
MHRT, primers F1 (Fig. 4k, CTGGAGCTGGGACAGGTCAGCA) and R1 were used. 
Those primers could also amplify endogenous MYH7 and thus serve as controls. Primers F2 
(Fig. 4k, TGGGGAACACGGCGTTCTTGA) and R2 were used to specifically amplify 
MHRT and used in RT-qPCR analysis.
PCR primers for RT-qPCR of mRNA:
Mouse TfIIb-F (CTCTGTGGCGGCAGCAGCTATTT),
Mouse TfIIb-R (CGAGGGTAGATCAGTCTGTAGGA),
Mouse Hprt1-F (GCTGGTGAAAAGGACCTCT),
Mouse Hprt1-R (CACAGGACTAGAACACCTGC),
Mouse Anf-F (GACTAGGCTGCAACAGCTTCCG),
Mouse Anf-R (GCCACAGTGGCAATGTGACCAA),
Mouse Serca2a-F (CATTTGCATTGCAGTCTGGAT),
Mouse Serca2a-R (CTTTGCCATCCTACGAGTTCC),
Mouse Tnnt2-F (TACAGACTCTGATCGAGGCTCACTTC),
Mouse Tnnt2-R (TCATTGCGAATACGCTGCTGCTC),
Mouse Mhrt-F (common) (GAGCATTTGGGGATGGTATAC),
Mouse Mhrt-R (common) (TCTGCTTCATTGCCTCTGTTT),
Mouse Mhrt779-F (TCTGGCCACAGCCCGCAGCTTC),
Mouse Mhrt779-R (AGTCATGTATACCATCCCCAA),
Mouse Neat1-F (TCTCCTGGAGCCACATCTCT)
Mouse Neat1-R (GCTTTTCCTTAGGCCCAAAC)
Mouse 28S-rRNA-F (GGTAGCCAAATGCCTCGTCAT)
Mouse 28S-rRNA-R (CCCTTGGCTGTGGTTTCG)
Human TFIIb-F (ACCACCCCAATGGATGCAGACAG),
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Human TFIIb-F (ACGGGCTAAGCGTCTGGCAC),
Human MHRT-F (F2, TGGGGAACACGGCGTTCTTGA),
Human MHRT-R (R2, GGGGCTGAAGAGTGAGCCTT).
Human HOTAIR-F (GGTAGAAAAAGCAACCACGAAGC)
Human HOTAIR-R (ACATAAACCTCTGTCTGTGAGTGCC)
Human GAPDH-F (CCGGGAAACTGTGGCGTGATGG)
Human GAPDH-R (AGGTGGAGGAGTGGGTGTCGCTGTT)
Chromatin immunoprecipitation–quantitative PCR (ChIP–qPCR)
ChIP assay was performed as described3 with modifications. Briefly, chromatin from hearts 
or SW13 cells was sonicated to generate average fragment sizes of 200–600 bp, and 
immunoprecipitated using anti-BRG1 J1 antibody3,40, anti-Brg1 H-10 antibody (Santa Cruz 
Biotechnology, against 115–149 amino acids of N-terminus Brg1), anti-RNA polymerase II 
(Pol II) antibody (ab24759, Abcam), anti-H3K4me3 antibody (07–473, Millipore), anti-
H3K36me3 antibody (17–10032, Millipore) or normal control IgG. Isolation and 
purification of immunoprecipitated and input DNA were done according to the 
manufacturer’s protocol (Magna ChIP Protein G Magnetic Beads, Millipore), and qPCR 
analysis of immunoprecipitated DNA were performed. ChIP–qPCR signal of individual 
ChIP reaction was standardized to its own input qPCR signal or IgG ChIP signal. PCR 
primers (listed below) were designed to amplify the promoter regions of mouse Myh6 (−426, 
−320), mouse Myh7 (−102, +58), mouse Shh (−7142, −6911), mouse Vegfa (+1, +150) 
human GAPDH (−45, +121). The DNA positions are denoted relative to the transcriptional 
start site (+1).
PCR primers for ChIP-qPCR:
Mouse ChIP-Myh6 promoter-F (GCAGATAGCCAGGGTTGAAA),
Mouse ChIP-Myh6 promoter-R (TGGGTAAGGGTCACCTTCTC),
Mouse ChIP-Myh7 promoter-F (GTGACAACAGCCCTTTCTAAAT),
Mouse ChIP-Myh7 promoter-R (CTCCAGCTCCCACTCCTACC),
Mouse ChIP-Shh promoter-F (GAGAACATTACAGGGTAGGAA),
Mouse ChIP-Shh promoter-R (GAAGCAGTGAGGTTGGTGG),
Mouse ChIP-Vegfa promoter-F (CAAATCCCAGAGCACAGACTC),
Mouse ChIP-Vegfa promoter-R (AGCGCAGAGGCTTGGGGCAGC),
Human ChIP-GAPDH promoter-F (TACTAGCGGTTTTACGGGCG),
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Human ChIP-GAPDH promoter-R (TCGAACAGGAGGAGCAGAGAGCGA).
RNA Immunoprecipitation
RNA Immunoprecipitation (RNA-IP, RIP) was conducted as described4 with some 
modifications. Briefly, P1 hearts, sham/TAC’ed hearts, or SW13 cells were cross-linked and 
lysed with Lysis Buffer (10 mM HEPES pH 7.5, 85 mM KCl, 0.5% NP-40, 1 mM DTT, 1 × 
protease inhibitor) for tissue and Lysis Buffer (10 mM Tris-HCl pH 8.1, 10 mM NaCl, 1.5 
mM MgCl2, 0.5% NP-40, 1 mM DTT, 1X protease inhibitor) for cell. Nuclei were isolated 
and sonicated using Bioruptor (Diagenode) (30 s on, 30 s off, power setting H, 5 minute for 
twice) in Nuclear Lysis buffer (50 mM Tris-HCl pH 8.1, 150 mM NaCl, 0.1% NP-40, 1 mM 
DTT, protease inhibitor, Ribonuclease inhibitor). The nuclear extract was collected and 
incubated with primary antibodies at 4°C for overnight together with Manga ChIP Protein G 
Magnetic Beads (Millipore). The beads were washed by Wash Buffer I (20 mM Tris-Hcl pH 
8.1, 150 mM NaCl, 1% Triton X-100 and 0.1% SDS) for three times, and Wash Buffer II 
(20 mM Tris-Hcl pH 8.1, 500 mM NaCl, 1% Triton X-100 and 0.1% SDS) for three times. 
Beads were then resuspended in 150 μl 150 mM RIPA (50 mM Tris pH 7.5, 150 mM NaCl, 
1 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate) with 5 μl Proteinase K 
and incubated for 1 h at 65°C. We added 1 ml of TRIzol to the sample, and RNA was 
extracted using the Quick-RNA Mini Kit with the on-column DNAse I digest 
(ZymoResearch). RT and qPCR were then conducted with the purified RNA. The antibodies 
used for the immunoprecipitation are anti-BRG1 J1 antibody3,40, Ezh241 (Active Motif), 
Suz1241,42 (Bethyl Laboratories) and normal IgG control.
Reporter assay and truncation of Mhrt promoter
For Mhrt promoter reporter assay, plasmid was constructed by inserting ~2.5Kbp mouse 
Mhrt promoter into the episomal pREP4-Luc plasmid3,19,38,43 through cloning PCR 
amplified region of the promoter by using primers ACCGGCCTGAACCCCACTTCC and 
ATGTCGAGACAGGGAACAGAA. Mouse Myh6 (−426 to +170, based on new genome 
annotation) and Myh7 (−3561 to +222) reporter constructs were described previously3. 
These vectors were transfected into rat neonatal cardiomyocytes or SW13 cells using 
lipofectamine 2000 (Invitrogen) along with plasmids expressing mouse Brg1 (Actin-mBrg1-
IRES-EGFP) or a matching empty vector plasmid (Gifts from Dr. G. Crabtree) as well as an 
episomal renilla-luciferase plasmid (pREP7-RL) to normalize transfection efficiency. The 
transfected cells were cultured for 48hrs and harvested for luciferase assay using the dual 
luciferase assay kit (Promega). For naked DNA reporter, mouse Myh6 promoter (−426 to 
+170) was inserted in pGL3 vector (Promega), and renilla-luciferase plasmid phRL-SV40 
(Gifts from Dr. J. Chen) was used as a normalizer. Dual luciferase assay was performed 
according to the manufacture’s instruction 48hrs after transfection. For deletional analysis of 
Mhrt promoter, various regions of the promoter were deleted from the full-length pREP4-
Mhrt. The constructs were further analysed by transfecting into SW13 cells.
RNA-EMSA and Kd calculation
Biotin-labeled RNA probe was generated by in vitro transcription with MAXIscript SP6/T7 
kit (Ambion) with biotin labeling NTP mixture (Roche) using linearized pDrive-Mhrt779 
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construct as the template and followed by digestion with DNase I (Ambion). The EMSA 
was performed by using the LightShift Chemiluminescent RNA EMSA Kit (Thermo 
Scientific). The labeled probe was incubated with appropriate amount of recombinant 
proteins in 10 μl in the 1 × binding buffer (10 mM HEPES-KOH, pH 7.3, 10 mM NaCl, 1 
mM MgCl2, 1 mM DTT) with 5 μg tRNA carrier at room temperature for 30 min. The 
reactions were then loaded onto 1% 0.5 × TBE agarose gel and transferred to BrightStar-
Plus positive charged membrane. The biotin-labeled probes were detected and quantified 
subsequently by IRDye 680 Streptavidin (Li-COR, 926–32231) using Odyssey Infrared 
Imaging System. The shifted signals were quantified and plotted against amount of the 
MBP, MBP-D1, MBP-D2 and MBP-D1D2 proteins using previously described method26 
with GraphPad Prism (GraphPad). The software facilitates the fitting of non-linear 
regression model and calculation of Kds (Dissociate Constant) based on the fitting curve. 
The errors and r-square (r2) were also generated from the fitting curve.
Protein expression and purification of Brg1 helicase domains
To generate MBP fusion proteins of mouse Brg1 helicase domains, the DExx-box domain 
(D1) (Amino acids 774–913 of Brg1), Helicase-C domain (D2) together with carboxyl-
terminal extension (CTE) (Amino acids 1086–1310 of Brg1), as well as the entire helicase 
region (D1D2) (774–1310) were amplified by PCR and cloned into pMAL vector. MBP 
fusion proteins were induced by IPTG and purified by Amylose resin (E8021S, NEB).
Nucleosome assembly and amylose pull-down
Nucleosome assembly was performed by using EpiMark Nucleosome Assembly Kit 
(E5350S, NEB) following the manufacture’s instruction28. In brief, recombinant human core 
histone octamer, which consist of the 2:1 mix of histone H2A/H2B dimer and histone 
H3.1/H4 tetramer, were mixed with purified 5SrDNA (208bp, N1202S, NEB), Neo (512bp, 
amplified from pST18-Neo, 1175025, Roche), Myh6 core promoter (596bp, −426 to +170) 
and Mhrt core promoter (a3a4, 596bp, −2290 to −1775) DNA at 2 M NaCl. PCR primers to 
amplify Neo are CGATGCGCTGCGAATCGGGA and CACTGAAGCGGGAAGGGACT. 
The salt concentration was gradually lowered by dilution to allow the formation of 
nucleosomes. The EMSA assay was used to assess the efficiency of nucleosome assembly. 
For amylose pull-down assay, the amylose resin (E8021S, NEB) was washed thoroughly 
and equilibrated with binding buffer (10 mM Tris-HCl, pH=7.5, 150 mM NaCl) before 
incubation with purified MBP, MBP-D1D2 proteins for 2hr. Nucleosome mixture or naked 
DNA mixture of 5S rDNA, Neo and Myh6 promoter DNA were added for incubation at 4°C 
for overnight. The resin was then washed excessively by washing buffer (20 mM Tris-HCl, 
pH=8.1, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS) before decrosslinking 
and extraction of the DNA with Phenol: Chloroform: Isoamyl Alcohol. For competition 
assay, in vitro transcribed Mhrt779 was incubated with MBP-D1D2 in binding buffer (10 
mM HEPES-KOH, pH 7.3, 10 mM NaCl, 1 mM MgCl2, 1 mM DTT) with Ribonuclease 
inhibitor at room temperature for 30 minutes before adding nucleosomal DNA. The 
subsequent incubation, wash and DNA purification were performed as regular amylose pull-
down assays. qPCR signal of individual pull-down reaction was standardized to its own 
input RT-qPCR signal. qPCR primers were designed to amplify the 5SrDNA 
(CAAGCAAGAGCCTACGACCA; ATTCGTTGGAATTCCTCGGG), Neo 
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(TAAAGCACGAGGAAGCGGTC; TCGACCACCAAGCGAAACAT), Myh6 promoter 
(GCAGATAGCCAGGGTTGAAA; TGGGTAAGGGTCACCTTCTC) and Mhrt promoter 
(ATGCCAAATGGTTGCTCTTT; GAGCTTGAGAACCAGGCAGT).
Cloning of Brg1 truncation constructs
For cloning of the truncated Brg1 with deletion of amino acids 774–913 (ΔD1) or 1086–
1246 (ΔD2), the primers with NheI restriction digestion site, which complement with the 
downstream and upstream of the truncated region (Δ D1: 
CCCGGGGCTAGCCTGCAGAACAAGCTACCGGAGCT and 
CCCGGGGCTAGCCAGGTTGTTGTTGTACAGGGACA; Δ D2: 
CCCGGGGCTAGCATCAAGAAGTTCAAATTTCCC and 
CCCGGGGCTAGCCTGCAGGCCATCCTGGAGCACGAGCAG) were used to amplify 
from pActin-Brg1-IRES-EGFP by KOD Xtreme Hot Start DNA Polymerase (Novagen). 
After digestion with NheI, the linearized fragment was subject to ligation and 
transformation. The truncation constructs were sequenced to confirm the fidelity of the 
cloning. Western Blot was further performed to assess the expression of the constructs. 
Monoclonal H-10 antibody (Santa Cruz Biotech, sc-374197), which were raised against 
Brg1 N-terminal amino acids, were used in the experiments involving the truncated Brg1.
Protein sequence analysis
Brg1 core helicase domain (774–1202) was applied for secondary structure prediction using 
the Fold & Function Assignment System (FFAS) server (http://ffas.burnham.org/ffas-
cgi/cgi/ffas.pl). The output revealed that Brg1 core helicase domain are structural homologs 
of SF2 helicases: Vasa44 (Fruit fly, PDB# 2DB3), Rad5427,45 (Zebrafish PDB# 1Z3I, 
Sulfolobus solfataricus PDB# 1Z63) and Chd146 (Yeast, PDB# 3MWY). Those proteins 
together with Brg1 were further employed for multiple sequence alignment with T-Coffee, 
which is a program allowing combination of the results obtained with several alignment 
methods (http://www.ebi.ac.uk/Tools/msa/tcoffee/).
RNA secondary structural prediction
To predict the secondary structure for mouse Mhrt and human MHRT, the single stranded 
sequence of Mhrt779 and human MHRT were analyzed on the Vienna RNAfold web server 
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) with calculation of minimum free 
energy29,47-49.
Human heart tissue analysis
The human tissues were processed for RT-qPCR and strand-specific RT-PCR. The use of 
human tissues is in compliance with the regulation of Sanford/Burnham Medical Research 
Institute, Intermountain Medical Center, Stanford University, and Indiana University.
Primary cardiomyocyte culture
For functional studies in cardiomyocytes, neonatal rat ventricular cardiomyocytes were 
cultured as previously described50,51. Briefly, P0 or P1 Sprague-Dawley rats were used. The 
ventricles were excised and trypsinized for 15 minutes for 4–5 times. Cells were then 
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collected and resuspended in DMEM supplements with 10% FBS. The cells were plated for 
1 h to allow the attachment of non-cardiomyocytes cells. The remaining cardiomyocytes 
were plated at a density of 2 × 105/ml. The cells were transfected with Lipofectamine 2000 
(Invitrogen) after 48 hr.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Profile of the non-coding RNA Mhrt
a, Schematic illustration of Mhrts originating from the intergenic region between Myh6 and 
Myh7 and transcribed into Myh7. Myh7 exons and introns are indicated. F1 and R1, targeting 
5' and 3′ Mhrt common sequences, are the primers used for subsequent PCR.
b, RT-qPCR of Mhrts using primers targeting common regions of Mhrts in tissues from 2-
month-old mice. P-value: Student’s t-test. Error bar: standard error of the mean (SEM).
c, RT-qPCR of Mhrt, Myh6 and Myh7 in mouse hearts at different ages. Mhrt and Myh6/
Myh7 ratio of E11 hearts are set as 1. Error bar: SEM.
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d, RNA in situ analysis of Mhrt (blue) in adult hearts. The RNA probe targets all Mhrt 
species. Red: nuclear fast red. White arrowheads: myocardial nuclei. Black arrowheads: 
nuclei of endothelial, endocardial or epicardial cells. Dashed lines demarcate the 
myocardium from endocardium (endo) or from epicardium (epi). Scale= 50 μm.
e, RT-qPCR of nuclear/cytoplasmic RNA in adult hearts. TfIIb, Hprt1, and 28SrRNA are 
primarily cytoplasmic RNAs; Neat1, nuclear lncRNA. TfIIb ratio is set as 1. P-value: 
Student’s t-test. Error bar: SEM.
f, Ribosome profiling: ribosome density on coding RNAs and lncRNAs.
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Figure 2. Mhrt inhibits cardiac hypertrophy and failure
a, Quantitation of cardiac Mhrts 2–42 days after TAC operation. P-value: Student’s t-test. 
Error bar: SEM.
b, RT-PCR of Mhrts in adult heart ventricles. Primers (F1 and R1, Fig. 1a) target Mhrt 
common regions. Size controls 779, 826, 709 are PCR products of recombinant Mhrt779, 
Mhrt826, and Mhrt709, respectively.
c, Northern blot of Mhrts in adult heart ventricles. The probe targets common regions of 
Mhrts. Negative: control RNA from 293T cells. Size control 826 is recombinant Mhrt826; 
643 (not a distinct Mhrt species) contains the 5′ common region of Mhrt.
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d Quantitation of Mhrt779 in control or Tg779 mice with/without doxycycline (Dox) or 
TAC operation. Mhrt779-specific PCR primers were used. Ctrl: control mice. Tg779: Tnnt2-
rtTA;Tre-Mhrt779 mice. P-value: Student’s t-test. Error bar: standard error of the mean 
(SEM).
e, Ventricle-body weight ratio of hearts 6 weeks after TAC. P-value: Student’s t-test. Error 
bar: SEM. Scale=1 mm.
f, Quantitation of cardiomyocyte size in control and Tg779 mice 6 weeks after TAC by 
wheat-germ agglutinin staining. P-value: Student’s t-test. Error bar: SEM.
g, Trichrome staining in control and Tg779 hearts 6 weeks after TAC. Red: cardiomyocytes. 
Blue: fibrosis.
h, i, Echocardiographic measurement of left ventricular fractional shortening (h) and 
internal dimensions at end-diastole (LVIDd) and end-systole (LVIDs) (i) 6 weeks after 
TAC. P-value: Student’s t-test. Error bar: SEM.
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Figure 3. Mhrt complexes with Brg1 through the helicase domain
a, DNaseI digital footprinting of Myh6/Mhrt promoter loci from ENCODE. Myh6 and Mhrt 
are transcribed in opposite directions as indicated by arrows. Bars represent DNA fragments 
protected from DNaseI digestion. Black boxes (a1-a4) refer to promoter regions with high 
sequences homology (Extended Data Fig. 4a).
b, Quantitation of Myh7/Myh6 ratio in control (Ctrl) and Tg779 (Tg) hearts 2 weeks after 
TAC. P-value: Student’s t-test. Error bar: standard error of the mean (SEM).
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c, RNA immunoprecipitation (RNA-IP) of Mhrt-Brg1 in ventricles from control hearts (Ctrl) 
with Sham/TAC operation; Tg779 hearts after TAC; Brg1-null (Tnnt2-rtTA;Tre-Cre;Brg1f/f) 
hearts after TAC; P1 hearts. P-value: Student’s t-test. Error bar: SEM.
d, ChIP analysis of Brg1 in control (Ctrl) and Tg779 hearts 2 weeks after TAC. Error bar: 
SEM.
e, Luciferase reporter assay of Myh6 and Myh7 promoters in neonatal rat cardiomyocytes. 
Vector: pAdd2 empty vector. Mhrt: pAdd2-Mhrt779. P-value: Student’s t-test. Error bar: 
SEM.
f, RNA-IP and EMSA of recombinant Brg1 proteins and in vitro transcribed Mhrt779. 
Biotin-labeled Mhrt779: 50 nM; unlabeled Mhrt779: 500 nM. P-value: Student’s t-test. Error 
bar: SEM.
g, Schematics of mouse Brg1 protein. The helicase core includes DExx-c and HELIC-c 
domain.
h, EMSA of Mhrt779 and Brg1 helicase. MBP: maltose binding protein. MBP-D1: MBP 
fused to Brg1 D1 (aa 774–913). MBP-D2: MBP fused to Brg1 D2 (aa 1086–1310). MBP-
D1D2: MBP fused to Brg1 D1D2 (aa 774–1310).
i, Binding affinity of Mhrt779 for MBP-tagged D1D2 determined by EMSA. Error bars 
represent the standard error from multiple independent measurements. Nonlinear regression 
curves were generated by GraphPad Prism.
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Figure 4. Mhrt inhibits chromatin targeting and gene regulation by Brg1
a, Gel electrophoresis and quantitation of nucleosomal 5SrDNA, Myh6 promoter and Neo 
DNA. Arrowheads: DNA-histone complex. Arrows: naked DNA. Nucleosome assembly 
efficiency is defined as the fraction of DNA bound to histones (arrowheads). P-value: 
Student’s t-test. Error bar: standard error of the mean (SEM).
b-d, Quantification of amylose pull-down of MBP-D1D2 (D1D2) with nucleosomal and 
naked Myh6 promoter DNA (b), with nucleosomal Myh6 promoter, Neo, and 5SrDNA (c), 
or with nucleosomal Myh6 promoter in the presence of Mhrt779 (d). P-value: Student’s t-
test. Error bar: SEM.
e, Amylose pull-down of MBP-D1D2 and histone 3. Anti-histone 3 and anti-MBP 
antibodies were used for western blot analysis.
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f, ChIP analysis of Brg1 on chromatinized and naked Myh6 promoter in rat ventricular 
cardiomyocytes. GFP: green fluorescence protein control. P-value: Student’s t-test. Error 
bar: SEM.
g, h, Luciferase reporter activity of Brg1 on naked Myh6 promoter (g) or of helicase-
deficient Brg1 on chromatinized Myh6 promoter (h) in rat ventricular cardiomyocytes. ΔD1: 
Brg1 lacking amino acid 774–913; ΔD2: Brg1 lacking 1086–1246. GFP: green fluorescence 
protein control. ChIP: H-10 antibody recognizing N-terminus, non-disrupted region of Brg1. 
P-value: Student’s t-test. Error bar: SEM.
i, j, ChIP analysis in SW13 cells of chromatinized Myh6 promoter in the presence of 
Mhrt779 (i) or helicase-deficient Brg1 (j). Vector: pAdd2 empty vector. Mhrt: pAdd2-
Mhrt779. P-value: Student’s t-test. Error bar: SEM.
k, Schematic illustration and PCR of human MHRT. MHRT originates from MYH7 and is 
transcribed into MYH7. MYH7 exons and introns are indicated. R1 and R2 are strand-
specific PCR primers; F1 and R1 target MHRT and MYH7; F2 and R2 are specific for 
MHRT.
l, Quantification of MHRT in human heart tissues. Ctrl: control. LVH: left ventricular 
hypertrophy. ICM: ischemic cardiomyopathy. IDCM: idiopathic dilated cardiomyopathy. P-
value: Student’s t-test. Error bar: SEM.
m, Working model of a Brg1-Mhrt negative feedback circuit in the heart. Brg1 represses 
Mhrt transcription, whereas Mhrt prevents Brg1 from recognizing its chromatin targets. 
Brg1 functions through two distinct promoter elements to bidirectionally repress Myh6 and 
Mhrt expression.
n, Molecular model of how Brg1 binds to its genomic DNA targets. Brg1 helicase (D1D2) 
binds chromatinized DNA, C-terminal extension (CTE) binds histone 3 (H3), and 
bromodomain binds acetylated (Ac) histone 3 or 4 (H4).
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Figure 5. 
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